SAN ANTONIO--(BUSINESS WIRE)--Integrative Health Technologies (IHTI) announces that its portfolio company, AlgaeCal International (www.algaecal.com), achieved record monthly sales of $228,052 in October 2007. AlgaeCal markets its plant-sourced calcium as a raw ingredient, finished products, and Bone-Health Program to the retail market and healthcare professionals. Its Bone-Health Program is in response to the U.S. Surgeon General’s “call to action” to the nutritional industry to develop bone health programs that would improve nutrition and increase physical activity and health literacy.
IHTI provides services for healthcare and nutritional companies including: (1) consulting and R & D for companies that lack sufficient in-house resources, (2) on-site biometric testing, and (3) independent clinical trials to validate the safety and efficacy of health-enhancing products. A listing of the Company’s press releases, SEC filings, and acquisition of its equity position in AlgaeCal can be found at (www.ihtglobal.com) under “Investor Relations Press Room.”
“Coincidentally,” said Dean Neuls, AlgaeCal’s president, “the current issue of Nutraceuticals World (NW) captures three fundamentals of our product and marketing program that we think explain our sales growth:
1. NW’s article on Marine Nutrition reports, “From cuisine to beauty, marine-derived products are in high demand these days…the market for marine nutraceuticals will continue to grow, as long as the technology and science behind these products remains solid.”
2. Stressing the importance of Ongoing Research, NW reports “Companies that put solid research behind their products are the ones that will gain significant market share in the long run.”
3. NW’s Bone Health Update reports that “the old standbys of low quality calcium-only products are no longer the focus of serious health savvy consumers…who…are looking for calcium blended with other minerals and nutrients essential for healthy bones.”
Forward-Looking Statement: Management makes forward-looking public statements concerning its expected future operations, performance and other developments. These are our best judgment estimates based upon current information, but involve risks and uncertainties. There are no assurances that other factors will not affect the accuracy of these statements since it is impossible to identify all relevant factors that could affect actual results. They include, but are not limited to, government regulation, managing and maintaining growth, effects of adverse publicity, litigation, competition and other factors.